The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01 CA218802
NIH
Grant: P30 CA060553
Northwestern University and Lurie Cancer Center
Grant: NIH R01 CA218802
National Institutes of Health
Grant: 5R01CA218802-04
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
FWCI
0.84
Citation Percentile
0.7%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals